PSUSA/00000703/202403
PSUSA/00000703/202403
PSUSA/00000703/202403
PSUSA/00003175/202403
PSUSA/00002254/202404
Mysimba Article-20 procedure - Timetable for the procedure
Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications - 2024-2025
Organisation chart: Information Management
Human medicines European public assessment report (EPAR): Apremilast Viatris, apremilast, Status: Application withdrawn
Annex to interim measures regarding notification of pharmacovigilance alerts by marketing authorisation holders under Regulation (EU) 2019/6: contact points
IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
Human medicines European public assessment report (EPAR): Stalevo, levodopa,carbidopa,entacapone, Date of authorisation: 17/10/2003, Revision: 30, Status: Authorised